Bodal Chemicals Limited (BOM:524370)
India · Delayed Price · Currency is INR 69.07
+1.19 (1.75%)
At close: Aug 14, 2026
Bodal Chemicals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 22,671 | 20,122 | 17,449 | 13,946 | 15,743 | 20,553 |
| 22,671 | 20,122 | 17,449 | 13,946 | 15,743 | 20,553 | |
Revenue Growth | 27.57% | 15.32% | 25.12% | -11.41% | -23.40% | 67.58% |
Cost of Revenue | 12,988 | 11,101 | 9,321 | 7,333 | 9,254 | 11,924 |
Gross Profit | 9,683 | 9,021 | 8,129 | 6,613 | 6,488 | 8,628 |
Selling, General & Admin | 1,296 | 1,283 | 1,166 | 1,039 | 962.12 | 1,120 |
Other Operating Expenses | 6,494 | 6,056 | 5,229 | 4,465 | 4,145 | 5,246 |
Operating Expenses | 8,485 | 8,036 | 7,080 | 6,109 | 5,638 | 6,832 |
Operating Income | 1,199 | 985.62 | 1,049 | 504.14 | 850.22 | 1,796 |
Interest Expense | -757.56 | -788.16 | -798.27 | -506.81 | -392.1 | -274.75 |
Interest & Investment Income | - | - | 70.69 | 104.13 | 78.86 | 120.06 |
Currency Exchange Gain (Loss) | - | - | -24.26 | 50.08 | -47.74 | -63.7 |
Other Non Operating Income (Expenses) | 173.96 | 152.98 | -13.62 | -30.03 | 1.78 | -16.7 |
EBT Excluding Unusual Items | 615.09 | 350.44 | 283.24 | 121.51 | 491.02 | 1,561 |
Gain (Loss) on Sale of Investments | - | - | 3.36 | -2.12 | 3.61 | 40.52 |
Gain (Loss) on Sale of Assets | 263.5 | 263.5 | 1.69 | 87.94 | 13.59 | 7.07 |
Other Unusual Items | -68.82 | -70.17 | -95.2 | -160.06 | 0.14 | -187.88 |
Pretax Income | 809.77 | 543.77 | 193.09 | 47.27 | 508.36 | 1,420 |
Income Tax Expense | 123.03 | 65.49 | 8.07 | -17.42 | 128.03 | 433.82 |
Earnings From Continuing Operations | 686.74 | 478.28 | 185.02 | 64.69 | 380.33 | 986.63 |
Minority Interest in Earnings | - | - | - | - | - | 55.65 |
Net Income | 686.74 | 478.28 | 185.02 | 64.69 | 380.33 | 1,042 |
Net Income to Common | 686.74 | 478.28 | 185.02 | 64.69 | 380.33 | 1,042 |
Net Income Growth | 135.10% | 158.50% | 186.01% | -82.99% | -63.51% | 148.27% |
Shares Outstanding (Basic) | 126 | 126 | 126 | 126 | 126 | 125 |
Shares Outstanding (Diluted) | 126 | 126 | 126 | 126 | 126 | 125 |
Shares Change | 1.15% | -0.02% | 0.08% | 0.19% | 0.10% | 2.34% |
EPS (Basic) | 5.45 | 3.80 | 1.47 | 0.51 | 3.03 | 8.31 |
EPS (Diluted) | 5.45 | 3.80 | 1.47 | 0.51 | 3.03 | 8.30 |
EPS Growth | 132.43% | 158.55% | 188.18% | -83.17% | -63.50% | 142.28% |
Free Cash Flow | - | 1,402 | 673.32 | -407.19 | -478.63 | -1,726 |
Free Cash Flow Per Share | - | 11.14 | 5.35 | -3.24 | -3.81 | -13.76 |
Dividend Per Share | - | - | - | - | 0.100 | 0.800 |
Dividend Growth | - | - | - | - | -87.50% | 0% |
Gross Margin | 42.71% | 44.83% | 46.58% | 47.42% | 41.22% | 41.98% |
Operating Margin | 5.29% | 4.90% | 6.01% | 3.62% | 5.40% | 8.74% |
Profit Margin | 3.03% | 2.38% | 1.06% | 0.46% | 2.42% | 5.07% |
Free Cash Flow Margin | - | 6.97% | 3.86% | -2.92% | -3.04% | -8.40% |
EBITDA | 1,901 | 1,682 | 1,720 | 1,098 | 1,374 | 2,259 |
EBITDA Margin | 8.39% | 8.36% | 9.86% | 7.87% | 8.73% | 10.99% |
D&A For EBITDA | 702.39 | 696.26 | 671.74 | 593.69 | 523.85 | 463.61 |
EBIT | 1,199 | 985.62 | 1,049 | 504.14 | 850.22 | 1,796 |
EBIT Margin | 5.29% | 4.90% | 6.01% | 3.62% | 5.40% | 8.74% |
Effective Tax Rate | 15.19% | 12.04% | 4.18% | - | 25.19% | 30.54% |
Revenue as Reported | 23,108 | 20,539 | 17,567 | 14,194 | 15,859 | 20,724 |
Advertising Expenses | - | - | 17.61 | 11.23 | 14.06 | 15.77 |